AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2020
Jun 19, 2020
34975_dirs_2020-06-19_02761a88-0f3d-48d1-a20b-00779d0b390d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-06-18
Reporting Person: Steele Susan M. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-18 | Common Stock | A | 28100 | $0.00 | Acquired | 37300 | Direct |
Footnotes
F1: Represents an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, and (ii) June 18, 2021.
F2: Includes (a) the award described in footnote (1) above and (b) an award of 9,200 restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17